DUBLIN--(BUSINESS WIRE)--The 'ABRYSVO Market Size, Forecast, and Market Insight - 2032' report has been added to ResearchAndMarkets.com's offering.

都柏林--（商业新闻短讯）--“ABRYSVO Market Size，Forecast，and Market Insight-2032”报告已添加到ResearchAndMarkets.com的产品中。

'ABRYSVO Market Size, Forecast, and Market Insight - 2032' report provides comprehensive insights about ABRYSVO for Respiratory syncytial virus (RSV) in the seven major markets. A detailed picture of the ABRYSVO for RSV in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 -2032 is provided in this report along with a detailed description of the ABRYSVO for RSV..

“ABRYSVO市场规模，预测和市场洞察-2032”报告提供了关于ABRYSVO在七个主要市场的呼吸道合胞病毒（RSV）的全面见解。本报告提供了2019-2032年研究期间美国、EU4（德国、法国、意大利和西班牙）、英国和日本7毫米范围内RSV ABRYSVO的详细图片，以及RSV ABRYSVO的详细描述。。

Pfizer's investigational RSV vaccine candidate, ABRYSVO (RSVpreF), builds on foundational basic science discoveries, including those made at the National Institutes of Health (NIH), which detailed the crystal structure of prefusion F, a key form of the viral fusion protein (F) that RSV uses to attack human cells.

辉瑞公司的研究性RSV候选疫苗ABRYSVO（RSVpreF）建立在基础基础科学发现的基础上，包括美国国立卫生研究院（NIH）的发现，其中详细描述了融合前F的晶体结构，融合前F是RSV用于攻击人类细胞的病毒融合蛋白（F）的关键形式。

The NIH research showed that antibodies specific to the prefusion form were highly effective at blocking virus infection, suggesting a prefusion F-based vaccine may confer optimal protection against RSV..

美国国立卫生研究院的研究表明，针对融合前形式的抗体在阻断病毒感染方面非常有效，这表明基于融合前F的疫苗可能会提供针对RSV的最佳保护。。

The report provides insights about mechanism of action, dosage and administration, as well as research and development including regulatory milestones, along with other developmental activities. Further, it also consists of future market assessments inclusive of the ABRYSVO market forecast analysis for RSV in the 7MM, SWOT, analysts' views, comprehensive overview of market competitors, and brief about other emerging therapies in RSV..

该报告提供了有关作用机制，剂量和给药以及研究和开发（包括监管里程碑）以及其他开发活动的见解。此外，它还包括未来的市场评估，包括7毫米级RSV的ABRYSVO市场预测分析、SWOT分析、分析师观点、市场竞争对手的全面概述，以及RSV其他新兴疗法的简介。。

ABRYSVO Analytical Perspective

ABRYSVO分析视角

In-depth ABRYSVO Market Assessment

深入的ABRYSVO市场评估

This report provides a detailed market assessment of ABRYSVO for Respiratory syncytial virus (RSV) in the seven major markets, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. This segment of the report provides forecasted sales data from 2024 to 2032..

本报告对美国、EU4（德国、法国、意大利和西班牙）、英国和日本等七个主要市场的呼吸道合胞病毒（RSV）的ABRYSVO进行了详细的市场评估。报告的这一部分提供了2024年至2032年的预测销售数据。。

ABRYSVO Clinical Assessment

ABRYSVO临床评估

The report provides the clinical trials information of ABRYSVO for RSV covering trial interventions, trial conditions, trial status, start and completion dates.

该报告提供了ABRYSVO针对RSV的临床试验信息，包括试验干预措施，试验条件，试验状态，开始和完成日期。

Scope of the Report

报告的范围

A comprehensive product overview including the ABRYSVO description, mechanism of action, dosage and administration, research and development activities in Respiratory syncytial virus (RSV).

全面的产品概述，包括ABRYSVO描述，作用机制，剂量和给药，呼吸道合胞病毒（RSV）的研究和开发活动。

Elaborated details on ABRYSVO regulatory milestones and other development activities have been provided in this report.

本报告详细介绍了ABRYSVO监管里程碑和其他开发活动。

The report also highlights the ABRYSVO research and development activities in RSV across the United States, Europe and Japan.

该报告还重点介绍了ABRYSVO在美国、欧洲和日本的RSV研发活动。

The report also covers the patents information with expiry timeline around ABRYSVO.

该报告还涵盖了ABRYSVO周围的专利信息和到期时间。

The report contains forecasted sales of ABRYSVO for RSV till 2032.

该报告包含截至2032年ABRYSVO对RSV的预测销售额。

Comprehensive coverage of the late-stage emerging therapies for RSV.

。

The report also features the SWOT analysis with analyst views for ABRYSVO in RSV.

该报告还对RSV的ABRYSVO进行了SWOT分析和分析。

Key Questions Answered

回答的关键问题

What is the product type, route of administration and mechanism of action of ABRYSVO?

ABRYSVO的产品类型、给药途径和作用机制是什么？

What is the clinical trial status of the study related to ABRYSVO in Respiratory syncytial virus (RSV) and study completion date?

与呼吸道合胞病毒（RSV）中ABRYSVO相关的研究的临床试验状态和研究完成日期是什么？

What are the key collaborations, mergers and acquisitions, licensing and other activities related to the ABRYSVO development?

与ABRYSVO开发相关的关键合作、并购、许可和其他活动是什么？

What are the key designations that have been granted to ABRYSVO for RSV?

授予ABRYSVO RSV的主要名称是什么？

What is the forecasted market scenario of ABRYSVO for RSV?

ABRYSVO对RSV的市场预测是什么？

What are the forecasted sales of ABRYSVO in the seven major countries, including the United States, Europe (Germany, France, Italy, Spain, and the United Kingdom), and Japan?

ABRYSVO在美国、欧洲（德国、法国、意大利、西班牙和英国）和日本等七个主要国家的预计销售额是多少？

What are the other emerging products available and how are these giving competition to ABRYSVO for RSV?

还有哪些其他新兴产品可用，这些产品如何与ABRYSVO竞争RSV？

Which are the late-stage emerging therapies under development for the treatment of RSV?

正在开发哪些治疗RSV的晚期新兴疗法？

Key Topics Covered:

涵盖的关键主题：

1. Report Introduction

1、报告简介

2. ABRYSVO Overview in RSV

2、RSV ABRYSVO概述

2.1. Product Detail

二点一。产品详细信息

2.2. Clinical Development

二点二。临床开发

2.2.1. Clinical studies

2.2.1。临床研究

2.2.2. Clinical trials information

2.2.2。临床试验信息

2.2.3. Safety and efficacy

2.2.3。安全性和有效性

2.3. Regulatory Milestones

二点三。监管里程碑

2.4. Other Developmental Activities

二点四。其他发展活动

2.5. Product Profile

二点五。产品简介

3. Competitive Landscape (Marketed Therapies)

3、竞争格局（市场疗法）

4. Competitive Landscape (Late-stage Emerging Therapies)

4、竞争格局（后期新兴疗法）

5. ABRYSVO Market Assessment

5.ABRYSVO市场评估

5.1. Market Outlook of ABRYSVO in RSV

5.1条。ABRYSVO在RSV的市场前景

5.2. 7MM Analysis

五点二。7MM分析

5.2.1. Market Size of ABRYSVO in the 7MM for RSV

5.2.1。ABRYSVO在RSV的7MM市场规模

5.3. Country-wise Market Analysis

五点三。国别市场分析

5.3.1. Market Size of ABRYSVO in the United States for RSV

5.3.1。ABRYSVO在美国的RSV市场规模

5.3.2. Market Size of ABRYSVO in Germany for RSV

5.3.2。ABRYSVO在德国的RSV市场规模

5.3.3. Market Size of ABRYSVO in France for RSV

5.3.3。

5.3.4. Market Size of ABRYSVO in Italy for RSV

5.3.4。意大利ABRYSVO的RSV市场规模

5.3.5. Market Size of ABRYSVO in Spain for RSV

5.3.5。西班牙ABRYSVO的RSV市场规模

5.3.6. Market Size of ABRYSVO in the United Kingdom for RSV

5.3.6。ABRYSVO在英国的RSV市场规模

5.3.7. Market Size of ABRYSVO in Japan for RSV

。ABRYSVO在日本的RSV市场规模

6. SWOT Analysis

6、SWOT分析

7. Analysts' Views

7、分析师意见

8. Appendix

8、附录

For more information about this report visit https://www.researchandmarkets.com/r/p7023m

有关此报告的更多信息，请访问https://www.researchandmarkets.com/r/p7023m

About ResearchAndMarkets.com

关于ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。